Triple

T13942277
Position Surface form Disambiguated ID Type / Status
Subject SARS-CoV-2 E335284 entity
Predicate fullName P16 FINISHED
Object Severe acute respiratory syndrome coronavirus 2 E335284 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Severe acute respiratory syndrome coronavirus 2 | Statement: [SARS-CoV-2, fullName, Severe acute respiratory syndrome coronavirus 2]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Severe acute respiratory syndrome coronavirus 2
Context triple: [SARS-CoV-2, fullName, Severe acute respiratory syndrome coronavirus 2]
  • A. SARS-CoV-2 chosen
    SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
  • B. COVID-19 pandemic
    The COVID-19 pandemic is a global outbreak of the coronavirus SARS-CoV-2 that began in late 2019, causing widespread illness, deaths, and major disruptions to societies and economies worldwide.
  • C. long COVID and post-acute sequelae of SARS-CoV-2 infection
    Long COVID and post-acute sequelae of SARS-CoV-2 infection refer to a range of persistent or new health problems that continue or emerge weeks to months after the initial COVID-19 illness, affecting multiple organ systems and daily functioning.
  • D. Omicron variant
    The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
  • E. SARS-CoV-2 spike glycoprotein
    The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d81c6081b88190b53e317c3370c8fe completed April 9, 2026, 9:38 p.m.
NER Named-entity recognition batch_69de2e0f6f3c8190a64058b732b0ac52 completed April 14, 2026, 12:07 p.m.
NED1 Entity disambiguation (via context triple) batch_69f7ce8bbd8c819084703298ed6d9c87 completed May 3, 2026, 10:39 p.m.
Created at: April 9, 2026, 10:17 p.m.